Diabetic Macular Edema

>

Latest News

Image Credit: ©Анастасия Луговская - stock.adobe.com
Researchers find experimental drug may prevent or slow vision loss in people with diabetes

May 30th 2023

Results of the study, published in the Journal of Clinical Investigation, showed evidence that an experimental drug called 32-134D may prevent or slow vision loss in people with diabetes.

Image Credit: ©18percentgrey - stock.adobe.com
Oxurion NV enrolls 108 patients in KALAHARI Phase 2, Part B clinical trial for diabetic macular edema

May 30th 2023

Image Credit: ©otello-stpdc - stock.adobe.com
Recruitment completed for Alimera's NEW DAY study

May 29th 2023

Image Credit: ©wladimir1804 - stock.adobe.com
AG-73305 phase 2a trial for the treatment of diabetic macular edema (DME) shows promising preliminary safety and efficacy data

May 25th 2023

Image Credit: ©Krakenimages.com - stock.adobe.com
Oculis reveals positive top line results for OCS-01 eye drops to treat DME during Stage 1 of its Phase 3 DIAMOND trial

May 22nd 2023

Video Series
Video Interviews
Latest CME Events & Activities

Medical Crossfire®: Expert Perspectives in Geographic Atrophy – How Can We Prepare for a New Era of Treatment?

View More

Community Practice Connections™: Ophthalmology and Oncology Perspectives on Integrating Novel Bispecific Antibodies Into the Uveal Melanoma Treatment Paradigm

View More

Medical Crossfire®: Ophthalmology and Oncology Perspectives on Integrating Novel Bispecific Antibodies Into the Uveal Melanoma Treatment Paradigm

View More

Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations

View More

Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations

View More

(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease

View More

(CME Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment

View More

(CME Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment

View More

(COPE Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment

View More

(COPE Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment

View More

C.R.U. Eye Symposium (Current, Relevant, Useful)

11/10/2023-11/12/2023

View More

C.R.U. Eye Symposium (Current, Relevant, Useful)

11/10/2023-11/12/2023

View More

Cases and Conversations™: New Treatment Strategies for nAMD & DME

07/28/2023

View More

Cases and Conversations™: New Treatment Strategies for nAMD & DME

07/28/2023

View More

Shared Perspectives in Managing Presbyopia – Understanding a New Paradigm for Optimizing Quality of Life

View More

Shared Perspectives in Managing Presbyopia – Understanding a New Paradigm for Optimizing Quality of Life

View More

Perfecting Co-Management of Glaucoma – Utilizing Development in the Spectrum of Treatment Options

View More

Perfecting Co-Management of Glaucoma – Utilizing Development in the Spectrum of Treatment Options

View More

Expert Insights in Geographic Atrophy with Transformative Care on the Horizon – Understanding the Complement System as a Target for Treatment

View More

Expert Insights in Geographic Atrophy with Transformative Care on the Horizon – Understanding the Complement System as a Target for Treatment

View More

(COPE Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

(COPE Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

(CME Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

More News

© 2023 MJH Life Sciences

All rights reserved.